Cy3G diminished inflammatory and fibrotic processes, thereby reducing cardiac hypertrophy both in vitro and in vivo via inhibition of the CTRP3/AMPK pathway 81. This evidence concerns the gene C1QTNF3 and cardiac hypertrophy.